Kunming Longjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 29, 2022 at 08:00 pm IST
Kunming Longjin Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 698.35 million compared to CNY 253.71 million a year ago. Revenue was CNY 702.52 million compared to CNY 254.03 million a year ago. Net income was CNY 3.09 million compared to CNY 11.81 million a year ago. Basic earnings per share from continuing operations was CNY 0.0077 compared to CNY 0.0295 a year ago. Diluted earnings per share from continuing operations was CNY 0.0077 compared to CNY 0.0295 a year ago.